Peanut-Allergic Patient Experiences After Epicutaneous Immunotherapy: Peanut Consumption and Impact on QoL

Immunoglobulin E (IgE)-mediated food allergy impacts 8% of US children,1 with peanut allergy prevalence steadily increasing.2 Food allergy affects everyday activities for food-allergic children and their parents,3 which can increase anxiety and reduce health-related quality of life (QoL).4, 5 Although several peanut-desensitization methods are being studied, no approved treatments exist for peanut-allergic patients.6, 7 Current research is mainly focused on efficacy and safety; however, it is important to consider participant QoL following peanut-immunotherapy clinical trials.

Source: Annals of Allergy, Asthma and Immunology - April 9, 2019 Category: Allergy & Immunology Authors: Megan O. Lewis, Terri F. Brown-Whitehorn, Antonella Cianferoni, Courtney Rooney, Jonathan M. Spergel Tags: Letters Source Type: research